The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global thyroid cancer diagnostics market is expected to grow from $2.62 billion in 2022 to $2.79 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The size of thyroid cancer diagnostics market is expected to reach $3.48 billion in 2027 at a CAGR of 5.7%.

North America held the largest thyroid cancer diagnostics market share, and Asia-Pacific was the fastest-growing region in 2022.

Thyroid Cancer Diagnostics Market Driver
The increasing prevalence of thyroid cancer is driving the growth of the thyroid cancer diagnostic market going forward. Thyroid cancer is a disease in the thyroid gland (a gland near the base of the throat that produces hormones to help regulate body temperature, heart rate, blood pressure, and weight). Thyroid cancer diagnostics help to discover thyroid cancer by providing early detection that can help improve treatment outcomes. Thus, the increasing prevalence of thyroid cancer increases the demand for the diagnostic market. For instance, in December 2020, according to the International Agency for Research on Cancer, a France-based intergovernmental agency, there were 586,202 new thyroid cancer cases and 43,646 deaths associated with those cases. Therefore, thyroid cancer’s increasing prevalence is propelling the diagnostic market of thyroid cancer.

View More On The Thyroid Cancer Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report

Prominent Thyroid Cancer Diagnostics Market Trend
Product innovation is a key trend gaining popularity in the thyroid cancer diagnostic market. Companies operating in the thyroid cancer diagnostic market are working on new product innovations to sustain their position in the market. For instance, in May 2020, Eli Lilly and Company introduced Retevmo (selpercatinib, 40 mg, and 80 mg capsules), approved by the U.S. Food and Drug Administration (FDA), a US-based government agency. This is the first therapy for patients with advanced RET-driven lung and thyroid cancers who require systemic therapy.

Thyroid Cancer Diagnostics Market Prominent Players
Major players in the thyroid cancer diagnostics market are Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Canon Inc., Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad and Genetics Inc.

Request A Sample Of The Global Thyroid Cancer Diagnostics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12030&type=smp

Key Thyroid Cancer Diagnostics Market Segments

The global thyroid cancer diagnostics market is segmented –
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users

The Thyroid Cancer Diagnostics Global Market Report 2023  provides a comprehensive overview on the thyroid cancer diagnostics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the thyroid cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Cancer Diagnostics Global Market Report 2023
Thyroid Cancer Drugs Global Market Report 2023
Cancer Monoclonal Antibodies Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model